Contact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
The FDA announced the availability of a draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and conduct of clinical trials, making them more agile without compromising data integrity or participant protections.
Continue readingApproval based on a clinical trial that demonstrated statistically significant reduction from baseline in mean monthly migraine days and improvements in function and reduction in activity impairment.
Continue readingApproval based on a clinical trial that demonstrated statistically significant reduction from baseline in mean monthly migraine days and improvements in function and reduction in activity impairment.
Continue readingApproval based on a clinical trial that demonstrated statistically significant reduction from baseline in mean monthly migraine days and improvements in function and reduction in activity impairment.
Continue readingSuccessful completion of a pharma industry-sponsored study to measure the electrophysiologic effects of ketamine on healthy brain function.
Continue readingThe data from the PADN-CFDA pivotal study provides strong evidence for the treatment of pulmonary arterial hypertension.
Continue readingSuperior quality Precision Plasmids™ expedite clinical trial timelines with no wait time to start manufacturing custom plasmids.
Continue readingThe FDA approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerations.
Continue readingOver the last two decades, biomedical researchers have begun to unravel cancer’s immense complexity, drilling down to the molecular level to better understand the genetic and biological changes that drive how cancers develop, grow, and spread.
Continue readingEating a Mediterranean diet, rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients.
Continue reading